Image of Derrick Lott

Derrick Lott


Derrick advises leading US and international public companies, as well as their boards of directors, on their transformative M&A transactions and other transactional matters. He has extensive experience advising publicly traded and privately held companies on domestic and cross-border transactions, including acquisitions and divestitures (including negotiated transactions, contested takeovers and topping bids), joint ventures, tender and exchange offers, minority investments, spinoffs and carveouts.

Derrick regularly counsels clients in a variety of industries, in a variety of industries, including healthcare and life sciences, technology, media & telecommunications and financial services, among others.

In addition, Derrick also regularly represents investment banks as financial advisors on M&A transactions.

In 2023, Derrick was recognized by Bloomberg Law in its ‘They’ve Got Next: 40 Under 40’, a Rising Star in Mergers & Acquisitions by Law360 and a Rising Star In Mergers & Acquisitions by New York Law Journal.


Representative matters

Public Company Mergers & Acquisitions:

CVS Health Corp. on its $10.6 billion acquisition of Oak Street Health.

Boston Scientific on its $3.7 billion acquisition of Axonics and its $615 million acquisition of Apollo Endosurgery.

JetBlue Airways Corp. on its $3.8 billion acquisition of Spirit Airlines.

GSK on its $5.1 billion acquisition of TESARO, Inc.

Unibail-Rodamco on its $25 billion acquisition of Westfield Corporation.

Dassault Systèmes S.E. on its $400 million acquisition of Exa Corporation.

Textron Inc. on its $247 million acquisition of Arctic Cat Inc.

Wausau Paper Corp. on its $514 million sale to Svenska Cellulosa Aktiebolaget.

Sun Pharmaceuticals Industries in its $48 million acquisition of InSite Vision Inc.

Pall Corporation on its $13.8 billion sale to Danaher Corporation.

Liberty Global plc on its $25 billion acquisition of Virgin Media.


Private Strategic Mergers & Acquisitions:

Boston Scientific on its $800 million divestiture of BTG Specialty Pharmaceuticals to portfolio companies of Charterhouse Capital Partners.

Altice USA, Inc. on its acquisition of Audience Partners, LLC, and its divestiture of a majority stake of Newsday to Patrick Dolan.

Bunge Limited on its divestiture of 35 U.S. interior elevators to Zen-Noh Grain Corporation.

S&P Global, Inc. on its divestiture of J.D. Power & Associates to XIO Group and its divestiture of the McGraw Hill Construction division to Symphony Technology Group.

Banco Bradesco S.A. on its $500 million acquisition of BAC Florida Bank.

General Electric Company on its sale of its energy finance business to Starwood Property Trust, Inc.

The National Hockey League’s Arizona Coyotes on the sale of 51% of the franchise to Andrew Barroway.

Pall Corporation on its acquisition of the life sciences business of ATMI, Inc.

Ardagh Group S.A. on its sale of Anchor Glass Container Corporation to KPS Capital Partners, LP.


Joint Ventures:

Société Générale on the formation of its joint venture with AllianceBernstein.

Altice USA, Inc. on its joint venture with, and its sale of a 49.99 percent of its LightPath fiber enterprise business to, Morgan Stanley Infrastructure Partners.

Bunge Limited on its joint venture with, and its acquisition of a 70% ownership interest in IOI Loders Croklaan from, IOI Corporation Berhad.

Anglo American on its sale of a minority shareholding in Anglo American Sur (Chile) to, and the negotiation of related partnership arrangements, with Mitsubishi Corporation.


Private Equity:

Tarsadia Capital on the sale of 100% of its interests in Igneo Holdings to Korea Zinc.

Amherst Pierpont Securities on its $600 million sale to Banco Santandar.

Ness Digital Engineering, a portfolio company of The Rohatyn Group (TRG), in its acquisition of Linium, LLC.

Pierpont Securities LLC in its merger with Amherst Securities Group LP.


Other Transactional Matters:

CVS Health Ventures on its $100 Series D investment in Carbon Health.

Altice USA, Inc. on its initial public offering of shares and its spin-off from Altice Europe N.V.

IG4 Capital on its cash tender offer for 12.29 percent of the common shares of Aenza S.A.A.

Liberty Global on its “modified Dutch Auction” tender offer to purchase up to $2.5 billion of its ordinary shares. 

LyondellBasell on its “modified Dutch Auction” tender offer to purchase up to 37,000,000 of its ordinary shares.

Speaking Engagements

  • Corporate Board Member’s 19th Annual Boardroom Summit – Panelist on “M&A Rules of Engagement for the Board”
  • Corporate Board Member’s 18th Annual Boardroom Summit – Panelist on “Would Your M&A Transaction Withstand a Shareholder Challenge?”
  • Corporate Board Member’s 17th Annual Boardroom Summit – Panelist on “The Board’s Role in Improving M&A Deal Outcomes”

Leadership Positions And Professional Affiliations

  • Fellow, Leadership Council on Legal Diversity (2017 Class)


  • Recommended Lawyer, M&A/Corporate and Commercial: M&A: Large Deals ($1BN+), Legal 500 USA, 2023 
  • Rising Star in Mergers & Acquisitions, Law360, 2023
  • Rising Star in Mergers & Acquisitions, New York Law Journal, 2023
  • ‘They’ve Got Next: 40 Under 40’ in Mergers & Acquisitions, Bloomberg Law, 2023
  • Rising Star, The Dealmaker Quarterly, 2019



New York, 2010


B.A., Economics, Washington & Lee University, 2006
J.D., American University Washington College of Law, 2009
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.